BHVN Summary

  1. NYSE
  2. >
  3. BHVN
TickerBHVN
DescriptionBIOHAVEN PHARMACEUTICAL HLDG CO LTD
Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees647
Next Earnings DateNovember 11th, 2020
IV64.310134%
IV Percentile12th
IV Rank10.60%
IV Skew5.470419
IV Skew Percentile30th
IV Skew SentimentBullish
Option Volume494
Volume184,024
Price$62.86
Previous Close$62.85
52-Week High$78.75
52-Week Low$26.56
50-Day Moving Avg.$65.31
200-Day Moving Avg.$54.46
10-Day Avg. Volume408,428
20-Day Avg. Volume394,702
30-Day Avg. Volume459,184
3-Month Avg. Volume569,150
EPS-$10.95
Outstanding Shares59,686,500
Float51,796,422
Market Capitalization$3,751,893,200
CurrencyUSD
UpdatedSeptember 18th, 2020